Mefenamic acid treatment to ward follicles development and progesterone level
article
OA: diamond
CC0
Abstract
Abstract Mefenamic acid is anti-inflammation non-steroid, which can hamper prostaglandin synthesis in the body tissue by hampering the siklooxigen enzyme. The purpose of this research is to find out the influence of Mefenamic acid toward the follicles development and progesterone level. This research is an experimental laboratory method. The subject of the research divided into five groups randomly selected and have been homogenized — one group as a control group and others as an experimental group with various dosages of Mefenamic acid treatment. The data is analyzed using a one-way Anova test. The results of this research are confirmed the significant difference of Grafian follicles, yellowish corpus luteum and progesterone level as the influence of Mefenamic acid. While there was no significant difference in tertiary follicles development. The decrease of corpus luteum is caused by Mephenamic acid activity to hamper the prostaglandin synthesis in the body tissue by hampering the siklooxigen enzyme. The prostaglandin can make follicles swelling and cause follicles fracture and make ovulation. The granulosis cell will make corpus luteum, which secreted progesterone hormone. Mefenamic acid was proven to avoid ovulation that blocked the formation of yellowish corpus luteum resulting in decreased blood progesterone level.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (12)
- W1003616632 via openalex
- W2150940329 via openalex
- W2193182282 via openalex
- W2412407799 via openalex
- W2527335739 via openalex
- W2594369745 via openalex
- W2756309405 via openalex
- W2758834386 via openalex
- W2911956155 via openalex
- W2913490360 via openalex
- W2921252347 via openalex
- W6744387411 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK